Global Orally Inhaled Generic Drugs Supply, Demand and Key Producers, 2024-2030

Page: 131

Published Date: 18 Apr 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Inhalation preparation is a special dosage form that is administered through the lungs. It can quickly and directly enter the lungs to exert drug effects through local administration, reducing the dosage and improving the efficacy of the drug. This report mainly focuses on orally inhaled generic drugs market.

The global Orally Inhaled Generic Drugs market size is expected to reach $ 924 million by 2030, rising at a market growth of 6.2% CAGR during the forecast period (2024-2030).

Inhaled drug delivery has the advantages of fast onset of action, rapid absorption, and few side effects. From the perspective of global mature markets, inhaled drug delivery is the mainstream treatment drug for respiratory diseases and the competitive landscape is relatively stable. There is great clinical demand in the field of inhaled formulations for asthma and COPD. China's market for asthma and inhaled preparations has broad prospects, and the rise of Chinese pharmaceutical companies is expected to come as China's domestic generic varieties are launched one after another.

This report studies the global Orally Inhaled Generic Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Orally Inhaled Generic Drugs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Orally Inhaled Generic Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Orally Inhaled Generic Drugs total production and demand, 2019-2030, (K Units)
Global Orally Inhaled Generic Drugs total production value, 2019-2030, (USD Million)
Global Orally Inhaled Generic Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Orally Inhaled Generic Drugs consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Orally Inhaled Generic Drugs domestic production, consumption, key domestic manufacturers and share
Global Orally Inhaled Generic Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Orally Inhaled Generic Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Orally Inhaled Generic Drugs production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Orally Inhaled Generic Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, AstraZeneca, Boehringer-Ingelheim, CTTQ, Sphsine, Daphne Pharmaceutical, Jewim Pharmaceutical, CF PharmTech, Xianju Pharmaceutical, Joincare Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Orally Inhaled Generic Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Orally Inhaled Generic Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Orally Inhaled Generic Drugs Market, Segmentation by Type:
    DPI
    MDI
    NEB

Global Orally Inhaled Generic Drugs Market, Segmentation by Application:
    Asthma
    COPD
    Inhalation Anesthesia
    Others

Companies Profiled:
    GSK
    AstraZeneca
    Boehringer-Ingelheim
    CTTQ
    Sphsine
    Daphne Pharmaceutical
    Jewim Pharmaceutical
    CF PharmTech
    Xianju Pharmaceutical
    Joincare Pharmaceutical
    Hengrui Medicine
    Purity Pharmaceutical

Key Questions Answered:
1. How big is the global Orally Inhaled Generic Drugs market?
2. What is the demand of the global Orally Inhaled Generic Drugs market?
3. What is the year over year growth of the global Orally Inhaled Generic Drugs market?
4. What is the production and production value of the global Orally Inhaled Generic Drugs market?
5. Who are the key producers in the global Orally Inhaled Generic Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Orally Inhaled Generic Drugs Introduction
    1.2 World Orally Inhaled Generic Drugs Supply & Forecast
        1.2.1 World Orally Inhaled Generic Drugs Production Value (2019 & 2023 & 2030)
        1.2.2 World Orally Inhaled Generic Drugs Production (2019-2030)
        1.2.3 World Orally Inhaled Generic Drugs Pricing Trends (2019-2030)
    1.3 World Orally Inhaled Generic Drugs Production by Region (Based on Production Site)
        1.3.1 World Orally Inhaled Generic Drugs Production Value by Region (2019-2030)
        1.3.2 World Orally Inhaled Generic Drugs Production by Region (2019-2030)
        1.3.3 World Orally Inhaled Generic Drugs Average Price by Region (2019-2030)
        1.3.4 North America Orally Inhaled Generic Drugs Production (2019-2030)
        1.3.5 Europe Orally Inhaled Generic Drugs Production (2019-2030)
        1.3.6 China Orally Inhaled Generic Drugs Production (2019-2030)
        1.3.7 Japan Orally Inhaled Generic Drugs Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Orally Inhaled Generic Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Orally Inhaled Generic Drugs Major Market Trends

2 Demand Summary
    2.1 World Orally Inhaled Generic Drugs Demand (2019-2030)
    2.2 World Orally Inhaled Generic Drugs Consumption by Region
        2.2.1 World Orally Inhaled Generic Drugs Consumption by Region (2019-2024)
        2.2.2 World Orally Inhaled Generic Drugs Consumption Forecast by Region (2025-2030)
    2.3 United States Orally Inhaled Generic Drugs Consumption (2019-2030)
    2.4 China Orally Inhaled Generic Drugs Consumption (2019-2030)
    2.5 Europe Orally Inhaled Generic Drugs Consumption (2019-2030)
    2.6 Japan Orally Inhaled Generic Drugs Consumption (2019-2030)
    2.7 South Korea Orally Inhaled Generic Drugs Consumption (2019-2030)
    2.8 ASEAN Orally Inhaled Generic Drugs Consumption (2019-2030)
    2.9 India Orally Inhaled Generic Drugs Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Orally Inhaled Generic Drugs Production Value by Manufacturer (2019-2024)
    3.2 World Orally Inhaled Generic Drugs Production by Manufacturer (2019-2024)
    3.3 World Orally Inhaled Generic Drugs Average Price by Manufacturer (2019-2024)
    3.4 Orally Inhaled Generic Drugs Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Orally Inhaled Generic Drugs Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Orally Inhaled Generic Drugs in 2023
        3.5.3 Global Concentration Ratios (CR8) for Orally Inhaled Generic Drugs in 2023
    3.6 Orally Inhaled Generic Drugs Market: Overall Company Footprint Analysis
        3.6.1 Orally Inhaled Generic Drugs Market: Region Footprint
        3.6.2 Orally Inhaled Generic Drugs Market: Company Product Type Footprint
        3.6.3 Orally Inhaled Generic Drugs Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Orally Inhaled Generic Drugs Production Value Comparison
        4.1.1 United States VS China: Orally Inhaled Generic Drugs Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Orally Inhaled Generic Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Orally Inhaled Generic Drugs Production Comparison
        4.2.1 United States VS China: Orally Inhaled Generic Drugs Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Orally Inhaled Generic Drugs Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Orally Inhaled Generic Drugs Consumption Comparison
        4.3.1 United States VS China: Orally Inhaled Generic Drugs Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Orally Inhaled Generic Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Orally Inhaled Generic Drugs Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Orally Inhaled Generic Drugs Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Orally Inhaled Generic Drugs Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Orally Inhaled Generic Drugs Production (2019-2024)
    4.5 China Based Orally Inhaled Generic Drugs Manufacturers and Market Share
        4.5.1 China Based Orally Inhaled Generic Drugs Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Orally Inhaled Generic Drugs Production Value (2019-2024)
        4.5.3 China Based Manufacturers Orally Inhaled Generic Drugs Production (2019-2024)
    4.6 Rest of World Based Orally Inhaled Generic Drugs Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Orally Inhaled Generic Drugs Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Orally Inhaled Generic Drugs Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Orally Inhaled Generic Drugs Production (2019-2024)

5 Market Analysis by Type
    5.1 World Orally Inhaled Generic Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 DPI
        5.2.2 MDI
        5.2.3 NEB
    5.3 Market Segment by Type
        5.3.1 World Orally Inhaled Generic Drugs Production by Type (2019-2030)
        5.3.2 World Orally Inhaled Generic Drugs Production Value by Type (2019-2030)
        5.3.3 World Orally Inhaled Generic Drugs Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Orally Inhaled Generic Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Asthma
        6.2.2 COPD
        6.2.3 Inhalation Anesthesia
        6.2.4 Others
    6.3 Market Segment by Application
        6.3.1 World Orally Inhaled Generic Drugs Production by Application (2019-2030)
        6.3.2 World Orally Inhaled Generic Drugs Production Value by Application (2019-2030)
        6.3.3 World Orally Inhaled Generic Drugs Average Price by Application (2019-2030)

7 Company Profiles
    7.1 GSK
        7.1.1 GSK Details
        7.1.2 GSK Major Business
        7.1.3 GSK Orally Inhaled Generic Drugs Product and Services
        7.1.4 GSK Orally Inhaled Generic Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 GSK Recent Developments/Updates
        7.1.6 GSK Competitive Strengths & Weaknesses
    7.2 AstraZeneca
        7.2.1 AstraZeneca Details
        7.2.2 AstraZeneca Major Business
        7.2.3 AstraZeneca Orally Inhaled Generic Drugs Product and Services
        7.2.4 AstraZeneca Orally Inhaled Generic Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 AstraZeneca Recent Developments/Updates
        7.2.6 AstraZeneca Competitive Strengths & Weaknesses
    7.3 Boehringer-Ingelheim
        7.3.1 Boehringer-Ingelheim Details
        7.3.2 Boehringer-Ingelheim Major Business
        7.3.3 Boehringer-Ingelheim Orally Inhaled Generic Drugs Product and Services
        7.3.4 Boehringer-Ingelheim Orally Inhaled Generic Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Boehringer-Ingelheim Recent Developments/Updates
        7.3.6 Boehringer-Ingelheim Competitive Strengths & Weaknesses
    7.4 CTTQ
        7.4.1 CTTQ Details
        7.4.2 CTTQ Major Business
        7.4.3 CTTQ Orally Inhaled Generic Drugs Product and Services
        7.4.4 CTTQ Orally Inhaled Generic Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 CTTQ Recent Developments/Updates
        7.4.6 CTTQ Competitive Strengths & Weaknesses
    7.5 Sphsine
        7.5.1 Sphsine Details
        7.5.2 Sphsine Major Business
        7.5.3 Sphsine Orally Inhaled Generic Drugs Product and Services
        7.5.4 Sphsine Orally Inhaled Generic Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Sphsine Recent Developments/Updates
        7.5.6 Sphsine Competitive Strengths & Weaknesses
    7.6 Daphne Pharmaceutical
        7.6.1 Daphne Pharmaceutical Details
        7.6.2 Daphne Pharmaceutical Major Business
        7.6.3 Daphne Pharmaceutical Orally Inhaled Generic Drugs Product and Services
        7.6.4 Daphne Pharmaceutical Orally Inhaled Generic Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Daphne Pharmaceutical Recent Developments/Updates
        7.6.6 Daphne Pharmaceutical Competitive Strengths & Weaknesses
    7.7 Jewim Pharmaceutical
        7.7.1 Jewim Pharmaceutical Details
        7.7.2 Jewim Pharmaceutical Major Business
        7.7.3 Jewim Pharmaceutical Orally Inhaled Generic Drugs Product and Services
        7.7.4 Jewim Pharmaceutical Orally Inhaled Generic Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Jewim Pharmaceutical Recent Developments/Updates
        7.7.6 Jewim Pharmaceutical Competitive Strengths & Weaknesses
    7.8 CF PharmTech
        7.8.1 CF PharmTech Details
        7.8.2 CF PharmTech Major Business
        7.8.3 CF PharmTech Orally Inhaled Generic Drugs Product and Services
        7.8.4 CF PharmTech Orally Inhaled Generic Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 CF PharmTech Recent Developments/Updates
        7.8.6 CF PharmTech Competitive Strengths & Weaknesses
    7.9 Xianju Pharmaceutical
        7.9.1 Xianju Pharmaceutical Details
        7.9.2 Xianju Pharmaceutical Major Business
        7.9.3 Xianju Pharmaceutical Orally Inhaled Generic Drugs Product and Services
        7.9.4 Xianju Pharmaceutical Orally Inhaled Generic Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Xianju Pharmaceutical Recent Developments/Updates
        7.9.6 Xianju Pharmaceutical Competitive Strengths & Weaknesses
    7.10 Joincare Pharmaceutical
        7.10.1 Joincare Pharmaceutical Details
        7.10.2 Joincare Pharmaceutical Major Business
        7.10.3 Joincare Pharmaceutical Orally Inhaled Generic Drugs Product and Services
        7.10.4 Joincare Pharmaceutical Orally Inhaled Generic Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Joincare Pharmaceutical Recent Developments/Updates
        7.10.6 Joincare Pharmaceutical Competitive Strengths & Weaknesses
    7.11 Hengrui Medicine
        7.11.1 Hengrui Medicine Details
        7.11.2 Hengrui Medicine Major Business
        7.11.3 Hengrui Medicine Orally Inhaled Generic Drugs Product and Services
        7.11.4 Hengrui Medicine Orally Inhaled Generic Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Hengrui Medicine Recent Developments/Updates
        7.11.6 Hengrui Medicine Competitive Strengths & Weaknesses
    7.12 Purity Pharmaceutical
        7.12.1 Purity Pharmaceutical Details
        7.12.2 Purity Pharmaceutical Major Business
        7.12.3 Purity Pharmaceutical Orally Inhaled Generic Drugs Product and Services
        7.12.4 Purity Pharmaceutical Orally Inhaled Generic Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Purity Pharmaceutical Recent Developments/Updates
        7.12.6 Purity Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Orally Inhaled Generic Drugs Industry Chain
    8.2 Orally Inhaled Generic Drugs Upstream Analysis
        8.2.1 Orally Inhaled Generic Drugs Core Raw Materials
        8.2.2 Main Manufacturers of Orally Inhaled Generic Drugs Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Orally Inhaled Generic Drugs Production Mode
    8.6 Orally Inhaled Generic Drugs Procurement Model
    8.7 Orally Inhaled Generic Drugs Industry Sales Model and Sales Channels
        8.7.1 Orally Inhaled Generic Drugs Sales Model
        8.7.2 Orally Inhaled Generic Drugs Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Orally Inhaled Generic Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Orally Inhaled Generic Drugs Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Orally Inhaled Generic Drugs Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Orally Inhaled Generic Drugs Production Value Market Share by Region (2019-2024)
 Table 5. World Orally Inhaled Generic Drugs Production Value Market Share by Region (2025-2030)
 Table 6. World Orally Inhaled Generic Drugs Production by Region (2019-2024) & (K Units)
 Table 7. World Orally Inhaled Generic Drugs Production by Region (2025-2030) & (K Units)
 Table 8. World Orally Inhaled Generic Drugs Production Market Share by Region (2019-2024)
 Table 9. World Orally Inhaled Generic Drugs Production Market Share by Region (2025-2030)
 Table 10. World Orally Inhaled Generic Drugs Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World Orally Inhaled Generic Drugs Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. Orally Inhaled Generic Drugs Major Market Trends
 Table 13. World Orally Inhaled Generic Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World Orally Inhaled Generic Drugs Consumption by Region (2019-2024) & (K Units)
 Table 15. World Orally Inhaled Generic Drugs Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World Orally Inhaled Generic Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Orally Inhaled Generic Drugs Producers in 2023
 Table 18. World Orally Inhaled Generic Drugs Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key Orally Inhaled Generic Drugs Producers in 2023
 Table 20. World Orally Inhaled Generic Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global Orally Inhaled Generic Drugs Company Evaluation Quadrant
 Table 22. World Orally Inhaled Generic Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Orally Inhaled Generic Drugs Production Site of Key Manufacturer
 Table 24. Orally Inhaled Generic Drugs Market: Company Product Type Footprint
 Table 25. Orally Inhaled Generic Drugs Market: Company Product Application Footprint
 Table 26. Orally Inhaled Generic Drugs Competitive Factors
 Table 27. Orally Inhaled Generic Drugs New Entrant and Capacity Expansion Plans
 Table 28. Orally Inhaled Generic Drugs Mergers & Acquisitions Activity
 Table 29. United States VS China Orally Inhaled Generic Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Orally Inhaled Generic Drugs Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China Orally Inhaled Generic Drugs Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based Orally Inhaled Generic Drugs Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Orally Inhaled Generic Drugs Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Orally Inhaled Generic Drugs Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Orally Inhaled Generic Drugs Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers Orally Inhaled Generic Drugs Production Market Share (2019-2024)
 Table 37. China Based Orally Inhaled Generic Drugs Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Orally Inhaled Generic Drugs Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Orally Inhaled Generic Drugs Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Orally Inhaled Generic Drugs Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers Orally Inhaled Generic Drugs Production Market Share (2019-2024)
 Table 42. Rest of World Based Orally Inhaled Generic Drugs Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Orally Inhaled Generic Drugs Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Orally Inhaled Generic Drugs Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Orally Inhaled Generic Drugs Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers Orally Inhaled Generic Drugs Production Market Share (2019-2024)
 Table 47. World Orally Inhaled Generic Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Orally Inhaled Generic Drugs Production by Type (2019-2024) & (K Units)
 Table 49. World Orally Inhaled Generic Drugs Production by Type (2025-2030) & (K Units)
 Table 50. World Orally Inhaled Generic Drugs Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Orally Inhaled Generic Drugs Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Orally Inhaled Generic Drugs Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World Orally Inhaled Generic Drugs Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World Orally Inhaled Generic Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Orally Inhaled Generic Drugs Production by Application (2019-2024) & (K Units)
 Table 56. World Orally Inhaled Generic Drugs Production by Application (2025-2030) & (K Units)
 Table 57. World Orally Inhaled Generic Drugs Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Orally Inhaled Generic Drugs Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Orally Inhaled Generic Drugs Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World Orally Inhaled Generic Drugs Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. GSK Basic Information, Manufacturing Base and Competitors
 Table 62. GSK Major Business
 Table 63. GSK Orally Inhaled Generic Drugs Product and Services
 Table 64. GSK Orally Inhaled Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. GSK Recent Developments/Updates
 Table 66. GSK Competitive Strengths & Weaknesses
 Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
 Table 68. AstraZeneca Major Business
 Table 69. AstraZeneca Orally Inhaled Generic Drugs Product and Services
 Table 70. AstraZeneca Orally Inhaled Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. AstraZeneca Recent Developments/Updates
 Table 72. AstraZeneca Competitive Strengths & Weaknesses
 Table 73. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
 Table 74. Boehringer-Ingelheim Major Business
 Table 75. Boehringer-Ingelheim Orally Inhaled Generic Drugs Product and Services
 Table 76. Boehringer-Ingelheim Orally Inhaled Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Boehringer-Ingelheim Recent Developments/Updates
 Table 78. Boehringer-Ingelheim Competitive Strengths & Weaknesses
 Table 79. CTTQ Basic Information, Manufacturing Base and Competitors
 Table 80. CTTQ Major Business
 Table 81. CTTQ Orally Inhaled Generic Drugs Product and Services
 Table 82. CTTQ Orally Inhaled Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. CTTQ Recent Developments/Updates
 Table 84. CTTQ Competitive Strengths & Weaknesses
 Table 85. Sphsine Basic Information, Manufacturing Base and Competitors
 Table 86. Sphsine Major Business
 Table 87. Sphsine Orally Inhaled Generic Drugs Product and Services
 Table 88. Sphsine Orally Inhaled Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Sphsine Recent Developments/Updates
 Table 90. Sphsine Competitive Strengths & Weaknesses
 Table 91. Daphne Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 92. Daphne Pharmaceutical Major Business
 Table 93. Daphne Pharmaceutical Orally Inhaled Generic Drugs Product and Services
 Table 94. Daphne Pharmaceutical Orally Inhaled Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Daphne Pharmaceutical Recent Developments/Updates
 Table 96. Daphne Pharmaceutical Competitive Strengths & Weaknesses
 Table 97. Jewim Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 98. Jewim Pharmaceutical Major Business
 Table 99. Jewim Pharmaceutical Orally Inhaled Generic Drugs Product and Services
 Table 100. Jewim Pharmaceutical Orally Inhaled Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Jewim Pharmaceutical Recent Developments/Updates
 Table 102. Jewim Pharmaceutical Competitive Strengths & Weaknesses
 Table 103. CF PharmTech Basic Information, Manufacturing Base and Competitors
 Table 104. CF PharmTech Major Business
 Table 105. CF PharmTech Orally Inhaled Generic Drugs Product and Services
 Table 106. CF PharmTech Orally Inhaled Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. CF PharmTech Recent Developments/Updates
 Table 108. CF PharmTech Competitive Strengths & Weaknesses
 Table 109. Xianju Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 110. Xianju Pharmaceutical Major Business
 Table 111. Xianju Pharmaceutical Orally Inhaled Generic Drugs Product and Services
 Table 112. Xianju Pharmaceutical Orally Inhaled Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Xianju Pharmaceutical Recent Developments/Updates
 Table 114. Xianju Pharmaceutical Competitive Strengths & Weaknesses
 Table 115. Joincare Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 116. Joincare Pharmaceutical Major Business
 Table 117. Joincare Pharmaceutical Orally Inhaled Generic Drugs Product and Services
 Table 118. Joincare Pharmaceutical Orally Inhaled Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 119. Joincare Pharmaceutical Recent Developments/Updates
 Table 120. Joincare Pharmaceutical Competitive Strengths & Weaknesses
 Table 121. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
 Table 122. Hengrui Medicine Major Business
 Table 123. Hengrui Medicine Orally Inhaled Generic Drugs Product and Services
 Table 124. Hengrui Medicine Orally Inhaled Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 125. Hengrui Medicine Recent Developments/Updates
 Table 126. Hengrui Medicine Competitive Strengths & Weaknesses
 Table 127. Purity Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 128. Purity Pharmaceutical Major Business
 Table 129. Purity Pharmaceutical Orally Inhaled Generic Drugs Product and Services
 Table 130. Purity Pharmaceutical Orally Inhaled Generic Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 131. Purity Pharmaceutical Recent Developments/Updates
 Table 132. Purity Pharmaceutical Competitive Strengths & Weaknesses
 Table 133. Global Key Players of Orally Inhaled Generic Drugs Upstream (Raw Materials)
 Table 134. Global Orally Inhaled Generic Drugs Typical Customers
 Table 135. Orally Inhaled Generic Drugs Typical Distributors


List of Figures
 Figure 1. Orally Inhaled Generic Drugs Picture
 Figure 2. World Orally Inhaled Generic Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Orally Inhaled Generic Drugs Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Orally Inhaled Generic Drugs Production (2019-2030) & (K Units)
 Figure 5. World Orally Inhaled Generic Drugs Average Price (2019-2030) & (US$/Unit)
 Figure 6. World Orally Inhaled Generic Drugs Production Value Market Share by Region (2019-2030)
 Figure 7. World Orally Inhaled Generic Drugs Production Market Share by Region (2019-2030)
 Figure 8. North America Orally Inhaled Generic Drugs Production (2019-2030) & (K Units)
 Figure 9. Europe Orally Inhaled Generic Drugs Production (2019-2030) & (K Units)
 Figure 10. China Orally Inhaled Generic Drugs Production (2019-2030) & (K Units)
 Figure 11. Japan Orally Inhaled Generic Drugs Production (2019-2030) & (K Units)
 Figure 12. Orally Inhaled Generic Drugs Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Orally Inhaled Generic Drugs Consumption (2019-2030) & (K Units)
 Figure 15. World Orally Inhaled Generic Drugs Consumption Market Share by Region (2019-2030)
 Figure 16. United States Orally Inhaled Generic Drugs Consumption (2019-2030) & (K Units)
 Figure 17. China Orally Inhaled Generic Drugs Consumption (2019-2030) & (K Units)
 Figure 18. Europe Orally Inhaled Generic Drugs Consumption (2019-2030) & (K Units)
 Figure 19. Japan Orally Inhaled Generic Drugs Consumption (2019-2030) & (K Units)
 Figure 20. South Korea Orally Inhaled Generic Drugs Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN Orally Inhaled Generic Drugs Consumption (2019-2030) & (K Units)
 Figure 22. India Orally Inhaled Generic Drugs Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of Orally Inhaled Generic Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Orally Inhaled Generic Drugs Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Orally Inhaled Generic Drugs Markets in 2023
 Figure 26. United States VS China: Orally Inhaled Generic Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Orally Inhaled Generic Drugs Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Orally Inhaled Generic Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Orally Inhaled Generic Drugs Production Market Share 2023
 Figure 30. China Based Manufacturers Orally Inhaled Generic Drugs Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Orally Inhaled Generic Drugs Production Market Share 2023
 Figure 32. World Orally Inhaled Generic Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Orally Inhaled Generic Drugs Production Value Market Share by Type in 2023
 Figure 34. DPI
 Figure 35. MDI
 Figure 36. NEB
 Figure 37. World Orally Inhaled Generic Drugs Production Market Share by Type (2019-2030)
 Figure 38. World Orally Inhaled Generic Drugs Production Value Market Share by Type (2019-2030)
 Figure 39. World Orally Inhaled Generic Drugs Average Price by Type (2019-2030) & (US$/Unit)
 Figure 40. World Orally Inhaled Generic Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 41. World Orally Inhaled Generic Drugs Production Value Market Share by Application in 2023
 Figure 42. Asthma
 Figure 43. COPD
 Figure 44. Inhalation Anesthesia
 Figure 45. Others
 Figure 46. World Orally Inhaled Generic Drugs Production Market Share by Application (2019-2030)
 Figure 47. World Orally Inhaled Generic Drugs Production Value Market Share by Application (2019-2030)
 Figure 48. World Orally Inhaled Generic Drugs Average Price by Application (2019-2030) & (US$/Unit)
 Figure 49. Orally Inhaled Generic Drugs Industry Chain
 Figure 50. Orally Inhaled Generic Drugs Procurement Model
 Figure 51. Orally Inhaled Generic Drugs Sales Model
 Figure 52. Orally Inhaled Generic Drugs Sales Channels, Direct Sales, and Distribution
 Figure 53. Methodology
 Figure 54. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

GSK
AstraZeneca
Boehringer-Ingelheim
CTTQ
Sphsine
Daphne Pharmaceutical
Jewim Pharmaceutical
CF PharmTech
Xianju Pharmaceutical
Joincare Pharmaceutical
Hengrui Medicine
Purity Pharmaceutical

Related Reports

Global Orally Inhaled Generic Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Orally Inhaled Generic Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 18 Apr 2024

date Pharma & Healthcare

Inhalation preparation is a special dosage form that is administered through the lungs. It can quickly and directly enter the lungs to exert drug effects through local administration, reducing the dosage and improving the efficacy of the drug. This report mainly focuses on orally inhaled generic drugs market.

Product Tags

Orally Inhaled Generic Drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>